Page last updated: 2024-10-17

aminocaproic acid and Sjogren's Syndrome

aminocaproic acid has been researched along with Sjogren's Syndrome in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez-Gronow, M1
Cuchacovich, M1
Grigg, DM1
Pizzo, SV1

Other Studies

1 other study available for aminocaproic acid and Sjogren's Syndrome

ArticleYear
Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis.
    Journal of molecular medicine (Berlin, Germany), 1996, Volume: 74, Issue:8

    Topics: Aminocaproic Acid; Arthritis, Rheumatoid; Autoantibodies; Binding Sites; Electrophoresis, Polyacryla

1996